COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,441 Articles (22,835 medRxiv, 8,606 bioRxiv)

Most recent first Previous |  Page 1491: Articles 14901-14910  | Next

Drug Repurposing for the SARS-CoV-2 Papain-Like Protease
Cho, C.-C. D., Li, S. G., Yang, K. S., Lalonde, T. J., Yu, G., Qiao, Y., Xu, S., Liu, W. R.
10.1101/2021.06.04.447160 — Posted: 2021-06-06
Loss of recognition of SARS-CoV-2 B.1.351 variant spike epitopes but overall preservation of T cell immunity
Riou, C., Keeton, R., Moyo-Gwete, T., Hermanus, T., Kgagudi, P., Baguma, R., Tegally, H., Doolabh, D., Iranzadeh, A., Tyers, L., Mutavhatsindi, H., Tincho, M., Benede, N., Marais, G., Chinhoyi, L., Mennen, M., Skelem, S., Bruyn, E., Stek, C., SA-CIN, , de Oliveira, T., Williamson, C., Moore, P., Wilkinson, R., Ntusi, N., Burgers, W.
10.1101/2021.06.03.21258307 — Posted: 2021-06-06
Temporal association of reduced serum vitamin D with COVID-19 infection: A single-institution case-control and historical cohort study
Gupta, D., Menon, S., Criqui, M. H., Sun, B. K.
10.1101/2021.06.03.21258330 — Posted: 2021-06-06
Individual-based modeling of COVID-19 transmission in college communities
Huang, Q., Ndeffo-Mbah, M., Mondal, A., Lee, S., Gurarie, D.
10.1101/2021.06.03.21258315 — Posted: 2021-06-06
The role of HIV infection in the clinical spectrum of COVID-19: a population-based cohort analysis based on US National COVID Cohort Collaborative (N3C) Enclave data
Yang, X., Zhang, J., Guo, S., Olatosi, B., Weissman, S. B., Li, X.
10.1101/2021.06.03.21258324 — Posted: 2021-06-06
Alcov: Estimating Variant of Concern Abundance from SARS-CoV-2 Wastewater Sequencing Data
Ellmen, I., Lynch, M. D. J., Nash, D., Cheng, J., Nissimov, J. I., Charles, T. C.
10.1101/2021.06.03.21258306 — Posted: 2021-06-06
NEW CORONAVIRUS IN PREGNANT WOMEN. Maternal and perinatal outcomes.
Sanchez, J., Espinosa, J., Caballero, L. C., Campana, S., Quintero, A., Luo, C., Ng, J., de Gracia, R., Vigil-De Gracia, P.
10.1101/2021.06.03.21258328 — Posted: 2021-06-06
Breadth of neutralising antibody responses to SARS-CoV-2 variants of concern is augmented by vaccination following prior infection: studies in UK healthcare workers and immunodeficient patients
Nadesalingam, A., Cantoni, D., Wells, D. A., Aguinam, E. T., Ferrari, M., Smith, P., Chan, A., Carnell, G., Ohlendorf, L., Einhauser, S., Wagner, R., Temperton, N. J., Castillo-Olivares, J. J., Baxendale, H., Heeney, J. L., Humoral immune Correlates from COVID-19 (HICC) Consortium
10.1101/2021.06.03.21257901 — Posted: 2021-06-06 Discussion: Onsite
ASSESSMENT OF PERFORMANCE AND IMPLEMENTATION CHARACTERISTICS OF RAPID POINT OF CARE SARS-CoV-2 ANTIGEN TESTING IN KENYA
Gitaka, J., Muthamia, E., Mbugua, S., Mungai, M., Bandawe, G., Qadri, F., Kawser, Z., Lockman, S., Ivers, L., Walt, D. R., Suliman, S., Mwau, M.
10.1101/2021.06.03.21258290 — Posted: 2021-06-06
Inferring SARS-CoV-2 RNA shedding into wastewater relative to time of infection
Cavany, S. M., Bivins, A., Wu, Z., North, D., Bibby, K., Perkins, A.
10.1101/2021.06.03.21258238 — Posted: 2021-06-06

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).